Are patients with multiple endocrine neoplasia type I prone to premature death? - Wikidata - wikimedia - TriplyDB

Are patients with multiple endocrine neoplasia type I prone to premature death?

Are patients with multiple endocrine neoplasia type I prone to premature death?

http://www.wikidata.org/entity/Q34064454

about

Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1 MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas.Update on pancreatic neuroendocrine tumors.Multiple endocrine neoplasia: the Chilean experience.Surgical treatment of endocrine pancreatic tumours.Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience.The current strategy for managing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1.MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1-Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression.Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.Fast-growing pancreatic neuroendocrine carcinoma in a patient with multiple endocrine neoplasia type 1: a case report.Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors.Biology and treatment of metastatic gastrointestinal neuroendocrine tumors.Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.Care for patients with multiple endocrine neoplasia type 1: the current evidence base.Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.Natural History of MEN1 GEP-NET: Single-Center Experience After a Long Follow-Up.Pancreatic neuroendocrine tumors: contemporary diagnosis and management.Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old.Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.Analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution.The future: genetics advances in MEN1 therapeutic approaches and management strategies.Multiple endocrine neoplasia type 1: duodenopancreatic tumours.Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours.Increased Expression of GLP-1R in Proliferating Islets of Men1 Mice is Detectable by [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 /PET.Preoperative assessment of the pancreas in multiple endocrine neoplasia type 1.Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers.Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose.Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory.

P2860

Q24647838-F94E1E28-51B4-410D-957E-0BD04E6DDE83 Q26998951-2BE06B08-0132-4E60-A349-349738D4BC29 Q28088746-81D4DF8B-DF25-41E1-B1E7-1924B6C890AB Q28296266-D94E1136-8FA6-40C0-80D3-44DB70907D5D Q30491060-5285E015-09DA-47AA-9D4F-5090BEE23403 Q31030383-9BFA871D-E4FC-4D9A-BEBC-FFEEB6B290CE Q34453043-D7FF830E-72F8-4853-98C6-0D526EEA5FE9 Q35895498-C689B993-C91A-4214-B9FF-641B13B79A44 Q35915012-F00DC296-6E3F-4004-B0D1-3A9E47F119CE Q35922060-A01513AC-1FC5-450C-AD63-AC88D115335A Q35987844-0C6383BA-97D4-42E4-ADE0-A769E8DB5EA7 Q36113256-07BE7327-F80E-4BBF-8FE3-ABD22CCB58A5 Q36192096-A730B216-1C97-4546-B7E8-8FE656A701A6 Q36911589-C3A1C727-3781-4605-987A-92EBE2A0B1BA Q37056120-B80D4441-2786-4D21-9E9A-DC6AF4FE62C0 Q37074258-76DEF463-1584-409D-94CC-17C67324A1E4 Q37074281-DCEC0B16-E326-49CC-9ABC-D3D69D21F037 Q37077832-2A7AB973-7778-4323-A750-9DF7C4E9497A Q37175960-5B368E73-906F-486B-9B12-44FB6BD8AF68 Q37808142-C08A0A15-E466-4E2B-B2EE-6057DB56F185 Q37981893-A453921E-356B-4859-8001-27C128AFAF30 Q38827497-F84C13FC-08AB-429B-A484-EB954AFFDDB2 Q38893809-F5A81F42-C011-4596-A237-C89BB963E576 Q39129029-ED65A51C-096E-4D8B-BB57-AC04A10F40E9 Q39412594-2137B239-143F-466B-9E79-5C88E71D53DA Q44489867-82AA3950-6B8E-48D5-9B6B-18EE6837F3EA Q47814736-08E52591-5B1F-4C51-885A-67F3442077D0 Q47901554-1D8D9F73-F9E5-40C6-8DD8-7FEC30570E8C Q48961547-C7D9E498-44B3-4CD8-BDA2-7ACBDBCA13A0 Q49165538-495372BE-3456-4820-B601-AD7819A69EA1 Q51356001-81D1CA84-5110-4C12-AC3A-ABE2AF3CC5CB Q51371210-31E50689-442E-47DB-9E0C-C72889F5E28C Q51493178-4BAC1B4D-EFF3-49C1-B550-8AD89F045D18 Q54638848-00A13B60-4435-46E2-8A7C-A54FD2C989FB Q54680442-89652C94-F62B-42AC-98F9-CFC6E321BC6B

P2860

Are patients with multiple endocrine neoplasia type I prone to premature death?

http://www.wikidata.org/entity/Q34064454

description

2000 nî lūn-bûn

@nan

2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Are patients with multiple endocrine neoplasia type I prone to premature death?

@ast

Are patients with multiple endocrine neoplasia type I prone to premature death?

@en

Are patients with multiple endocrine neoplasia type I prone to premature death?

@nl

type

label

Are patients with multiple endocrine neoplasia type I prone to premature death?

@ast

Are patients with multiple endocrine neoplasia type I prone to premature death?

@en

Are patients with multiple endocrine neoplasia type I prone to premature death?

@nl

prefLabel

Are patients with multiple endocrine neoplasia type I prone to premature death?

@ast

Are patients with multiple endocrine neoplasia type I prone to premature death?

@en

Are patients with multiple endocrine neoplasia type I prone to premature death?

@nl

P1433

Q34064454-DED71763-D789-48A5-B4F0-56F64B30EA3F

P1476

Q34064454-51032049-C61C-4088-810E-941C4B436A5A

P2093

Q34064454-0D462CE9-9949-4666-8A64-925C700F2C10

Q34064454-1517D741-E511-4A75-902B-3600B23BB994

Q34064454-2A0AC461-B12C-480C-AE8F-F0A6D1E88996

Q34064454-4B32F282-E306-470E-94B7-F3A88EBE6F86

Q34064454-6E2FBD46-A30F-43D8-8EE5-6BA9BB530628

Q34064454-AF4342AC-8345-4147-AAA9-5066576F2D8F

Q34064454-D87A1576-85C6-421F-ADA3-B0FF0C6FA846

P2888

Q34064454-FD6A94ED-8210-4EAE-9C9E-FB2E705014C1

P304

Q34064454-397C8EFB-F7E0-49FE-93E7-BF8A0E5FC36D

P31

Q34064454-0909CBF5-14E7-4A7A-B4D5-4AF059FDBDEA

P356

Q34064454-17BC4E02-3D7C-43F3-84B2-85FD4BFFB5CE

P433

Q34064454-292B2C99-06D2-4DD4-9BB7-AE3B8C3B8ACE

P478

Q34064454-37D4AB4C-7243-4D12-B79D-80A4DB795F6E

P577

Q34064454-2F754171-C1CF-4E36-8442-995667C890C6

P6179

Q34064454-7022AA27-BBAB-43DC-B29D-C1C4388F3F77

P698

Q34064454-29991E15-DFBD-41AA-BDAB-A4E55C7991C5

P921

Q34064454-3251CC38-2025-42F0-8225-F3D528CFBF26

P356

P1433

World Journal of Surgery

P1476

Are patients with multiple endocrine neoplasia type I prone to premature death?

@en

P2093

Dean PG

http://www.w3.org/2001/XMLSchema#string

Farley DR

http://www.w3.org/2001/XMLSchema#string

Grant CS

http://www.w3.org/2001/XMLSchema#string

Harmsen WS

http://www.w3.org/2001/XMLSchema#string

Ilstrup DM

http://www.w3.org/2001/XMLSchema#string

Thompson GB

http://www.w3.org/2001/XMLSchema#string

van Heerden JA

http://www.w3.org/2001/XMLSchema#string

P2888

P304

1437-1441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S002680010237

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2000-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020335399

http://www.w3.org/2001/XMLSchema#string

P698

11038219

http://www.w3.org/2001/XMLSchema#string

P921